Palisade Capital Management LLC Mannkind Corp Transaction History

Palisade Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$2.67 - $4.77 $29,370 - $52,469	-11,000 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$4.05 - $5.37 $44,550 - $59,070	11,000 New	11,000 $48,000
Q2 2021 Aug 12, 2021	SELL	$3.61 - $5.45 $46,930 - $70,850	-13,000 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$3.14 - $6.14 $40,820 - $79,820	13,000 New	13,000 $51,000

244

148M

1.62M

802K

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.57B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

Get notified when there are updates to the investment portfolio of Palisade Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Palisade Capital Management LLC with notifications on news.